Emrosi™ (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea ...
A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe ...
Medpage Today on MSN4mon
FDA Approves New Option for RosaceaThe FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...
He said, “100-mg and 40-mg doses both show the same 16-week efficacy” in decreasing the number of inflammatory lesions, noting that “we don’t need [the higher dose] to accomplish the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results